References
- Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J. and Suda, T. : Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600 (1988). https://doi.org/10.1210/endo-123-5-2600
- Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. : Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345 (1999). https://doi.org/10.1210/edrv.20.3.0367
- Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S. 3rd, Frankel, W. N., Lee, S. Y. and Choi, Y. : TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J. Biol. Chem. 272, 25190 (1997). https://doi.org/10.1074/jbc.272.40.25190
- Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T. : Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95, 3597 (1998). https://doi.org/10.1073/pnas.95.7.3597
- Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W. J. : Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165 (1998). https://doi.org/10.1016/S0092-8674(00)81569-X
- Murphy, R. C., Gijon, M. A. : Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379 (2007). https://doi.org/10.1042/BJ20070289
- Rådmark, O., Werz, O., Steinhilber, D. and Samuelsson, B. : 5- Lipoxygenase: Regulation of expression and enzyme activity. Trends Biochem. Sci. 32, 332 (2007). https://doi.org/10.1016/j.tibs.2007.06.002
- Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. and Shimizu, T. : A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620 (1997). https://doi.org/10.1038/42506
- Yokomizo, T., Kato, K., Terawaki, K., Izumi, T. and Shimizu, T. : A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421 (2000). https://doi.org/10.1084/jem.192.3.421
- Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D. S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., Connolly, B. M., Bai, C., Austin, C. P., Chateauneuf, A., Stocco, R., Greig, G. M., Kargman, S., Hooks, S. B., Hosfield, E., Williams, D. L. Jr., Ford-Hutchinson, A. W., Caskey, C. T. and Evans, J. F. : Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789 (1999). https://doi.org/10.1038/21658
- Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen. T., Im, D. S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., Williams, D. L. Jr., Zeng, Z., Liu, Q., Ma, L., Clements, M. K., Coulombe, N., Liu, Y., Austin, C. P., George, S. R., O'Neill, G. P., Metters, K. M., Lynch, K. R. and Evans, J. F. : Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275, 30531 (2000). https://doi.org/10.1074/jbc.M003490200
- Takasaki, J., Kamohara, M., Matsumoto, M., Saito, T., Sugimoto, T., Ohishi, T., Ishii, H., Ota, T., Nishikawa, T., Kawai, Y., Masuho, Y., Isogai, T., Suzuki, Y., Sugano, S. and Furuichi, K. : The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem. Biophys. Res. Commun. 274, 316 (2000). https://doi.org/10.1006/bbrc.2000.3140
- Rådmark O. and Samuelsson B. : Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis. Biochem Biophys Res Commun. 396, 105 (2010). https://doi.org/10.1016/j.bbrc.2010.02.173
- Bonewald, L. F., Flynn, M., Qiao, M., Dallas, M. R., Mundy, G. R. and Boyce, B. F. : Mice lacking 5-lipoxygenase have increased cortical bone thickness. Adv. Exp. Med. Biol. 433, 299 (1997).
- Cottrell, J. A. and O'Connor, J. P. : Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J. Bone. Joint. Surg. Am. 91, 2653 (2009). https://doi.org/10.2106/JBJS.H.01844
- Manigrasso, M. B. and O'Connor, J. P. : Accelerated fracture healing in mice lacking the 5-lipoxygenase gene. Acta. Orthop. 81, 748 (2010). https://doi.org/10.3109/17453674.2010.533931
- Paredes, Y., Massicotte, F., Pelletier, J. P., Martel-Pelletier, J., Laufer, S. and Lajeunesse, D. : Study of the role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum. 46, 1804 (2002). https://doi.org/10.1002/art.10357